Bropirimine

An immunomodulatory drug

Bropirimine
File:Bropirimine.png
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number	3673-92-3
PubChem	2467
DrugBank
ChemSpider	2373
KEGG	D03001

Bropirimine is a synthetic immunomodulatory drug that has been investigated for its potential use in the treatment of various cancers and viral infections. It is known for its ability to induce the production of interferon, a protein that plays a critical role in the body's immune response.

Mechanism of Action

Bropirimine functions primarily as an immunomodulator. It stimulates the production of interferon-alpha, a type of cytokine that enhances the immune system's ability to fight off pathogens and tumor cells. By increasing interferon levels, bropirimine helps to activate natural killer cells and macrophages, which are essential components of the innate immune system.

Clinical Applications

Bropirimine has been studied for its potential use in treating bladder cancer, particularly in cases where intravesical therapy is required. It has also been explored as a treatment for certain viral infections, including those caused by the human papillomavirus (HPV).

Bladder Cancer

In the context of bladder cancer, bropirimine is administered intravesically, meaning it is directly instilled into the bladder. This localized delivery allows for high concentrations of the drug at the site of the tumor, potentially enhancing its effectiveness while minimizing systemic side effects.

Viral Infections

Bropirimine's ability to induce interferon production makes it a candidate for treating viral infections. By boosting the body's natural antiviral defenses, it may help to control or reduce the severity of infections caused by viruses such as HPV.

Side Effects

The use of bropirimine can be associated with several side effects, primarily due to its immunostimulatory effects. Common side effects include flu-like symptoms, such as fever, chills, fatigue, and muscle aches. These symptoms are generally mild and resolve after discontinuation of the drug.

Research and Development

Bropirimine has been the subject of various clinical trials aimed at evaluating its efficacy and safety in different therapeutic contexts. While promising results have been observed in some studies, further research is needed to fully establish its clinical utility and to optimize its dosing regimens.

Related Pages

• Immunotherapy
• Interferon
• Bladder cancer
• Viral infection